Clinical Trials
3 trialsNCT03094052 2025-06-26
Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib
University of California, San Francisco
Phase 2 Completed
NCT07016737 2025-06-12
ESO-Nanjing12
Jiangsu Cancer Institute & Hospital
Phase 3 Enrolling by invitation
NCT00583323 2014-08-21
Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET
Mayo Clinic
Phase 3 Completed